Professor Bhaskar Somani
Professor of Urology and Consultant Endourologist
Bhaskar Somani is a Professor of Urology and a Consultant Endourologist at University Hospital Southampton – MRCS, DM, FEBU, FFSTEd, FRCS (Urol) – and spokesperson for The Urology Foundation
Professor Bhaskar Somani has been involved in clinically innovative patient-centred treatments. His research includes minimally invasive surgical techniques in management of kidney stone disease, enlarged prostate (BPH), renal cancer and urinary tract infections. He is the Clinical Director of ‘South Coast Lithotripter Services’.
Over the last 8 years his clinical and research work has been covered by BBC, ITV, Daily Mail, The Telegraph and other newspapers and media articles on a number of occasions. He has raised awareness in highlighting risk factors for development of kidney stones such as dehydration, diet and obesity. His new innovative treatment methods include laser pop-dusting for stones.
He is an active member of BAUS Endourology sub-section and is the Wessex Clinical Research Network and Simulation Lead for Urology. He is the President of PETRA (Progress in Endourology, Technology and Research Association) Urogroup and an active member of European School of Urology (ESU) Training and Research group.
His current research interests include vaccination for urinary tract infections, new minimally invasive prostate treatments, laser surgery for eroded vaginal mesh, complex renal stone surgery and post-surgery quality of life measurements.
He coordinates the largest hands-on-training simulation course for urology in the world (EUREP). He has published over 250 scientific papers and has been invited as a speaker, to perform live surgery and for moderations in more than 25 countries worldwide. With dedication, commitment and passion for research and teaching, he collaborates successfully nationally and internationally sharing his research and teaching across the world. He has published excellent clinical outcomes and his outcome and research translate into patient benefit.